Core Viewpoint - The company Mengjie Co., Ltd. reported a decline in revenue but an increase in net profit for the first three quarters of 2025, raising concerns about the accuracy of the financial report due to internal dissent among board members [1][2]. Financial Performance - The company achieved operating revenue of approximately 1.099 billion yuan, a year-on-year decrease of 7.97% [1]. - The net profit attributable to shareholders was approximately 26.52 million yuan, reflecting a year-on-year increase of 28.69% [1]. - The net profit after deducting non-recurring gains and losses was 24.75 million yuan, showing a significant year-on-year growth of 105.37% [1]. Internal Disputes - Board member Chen Jie expressed doubts about the authenticity and completeness of the Q3 report, citing multiple reasons for opposition or abstention during the board meeting [1]. - Chen Jie has a history of voting against the company's periodic financial reports, including the annual report for 2024 and the Q1 report for 2025 [2]. Regulatory Issues - The company faced regulatory scrutiny from the Hunan Securities Regulatory Bureau due to two major violations, which included issues with revenue and cost recognition, as well as improper accounting for employee compensation and social security [1]. Financial Management Concerns - The subsidiary, Fujian Dafang Sleep Technology Co., Ltd., provided financial assistance to an individual named Ye Yifeng, with outstanding loans amounting to 66.03 million yuan as of December 31, 2021, and 63.38 million yuan as of September 30, 2025 [2]. - The company and its subsidiaries exhibited inadequate financial management and internal control, failing to pursue the recovery of borrowed funds from Ye Yifeng [2].